Mylan was slammed by people unable to afford its lifesaving EpiPen injection device following a price hike — its response was seen as too little, too late.
Mayo Clinic CEO John Noseworthy on the role of comms in healthcare
Mayo Clinic’s CEO talks about how a trusted name in healthcare has evolved digitally and centered communications on its newsroom while retaining integrity.
Reputation Institute: Talc lawsuits not hurting J&J’s image with millennials
According to research conducted in the first quarter, the healthcare products company has a sterling image with millennials despite a series of legal judgments against the company.